The Effects of Contraceptive Pill and Hormonal Vaginal Ring on Hormonal, Inflammatory and Metabolic Parameters in Women of Reproductive Age With Polycystic Ovary Syndrome (PCOS). [Ehkäisytabletin ja ehkäisyrenkaan vaikutukset hormonaalisiin, tulehduksellisiin ja aineenvaihdunnallisiin parametreihin naisilla, joilla on polykystinen munasarjaoireyhtymä (PCOS).]

Trial Profile

The Effects of Contraceptive Pill and Hormonal Vaginal Ring on Hormonal, Inflammatory and Metabolic Parameters in Women of Reproductive Age With Polycystic Ovary Syndrome (PCOS). [Ehkäisytabletin ja ehkäisyrenkaan vaikutukset hormonaalisiin, tulehduksellisiin ja aineenvaihdunnallisiin parametreihin naisilla, joilla on polykystinen munasarjaoireyhtymä (PCOS).]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2013

At a glance

  • Drugs Ethinylestradiol/desogestrel (Primary) ; Ethinylestradiol/etonogestrel (Primary)
  • Indications Polycystic ovary syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Mar 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2012-002220-32).
    • 08 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top